Accendra Health (ACH) EBIT (2009 - 2026)

Accendra Health (ACH) has 18 years of EBIT data on file, last reported at $17.1 million in Q1 2026.

• EBIT for Q1 2026 came in at $17.1 million, down 13.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24.1 million (up 88.25% YoY), and the FY2025 annual result was -$21.4 million, up 90.17% from the prior year.
• EBIT grew to $17.1 million in Q1 2026 per ACH's latest filing, from -$28.0 million in the prior quarter.
• Over five years, EBIT peaked at $88.7 million in Q4 2023 and troughed at -$272.7 million in Q4 2024.
• A 5-year average of $3.3 million and a median of $17.1 million in 2026 frame the typical range for EBIT.
• The sharpest annual moves came in 2023 and 2024: EBIT soared 265.94% in 2023, then tumbled 407.29% in 2024.
• A 5-year view of EBIT shows it stood at -$53.5 million in 2022, then soared by 265.94% to $88.7 million in 2023, then plunged by 407.29% to -$272.7 million in 2024, then soared by 89.75% to -$28.0 million in 2025, then surged by 161.25% to $17.1 million in 2026.
• Business Quant data shows ACH's EBIT at $17.1 million in Q1 2026, -$28.0 million in Q4 2025, and $26.5 million in Q3 2025.